Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment.
Beelen K, Opdam M, Severson TM, Koornstra RH, Vincent AD, Hauptmann M, van Schaik RH, Berns EM, Vermorken JB, van Diest PJ, Linn SC. Beelen K, et al. Among authors: van diest pj, van schaik rh. Breast Cancer Res Treat. 2013 Jun;139(3):649-55. doi: 10.1007/s10549-013-2568-0. Epub 2013 Jun 5. Breast Cancer Res Treat. 2013. PMID: 23736997 Free PMC article. Clinical Trial.
St. Gallen endocrine response classes predict recurrence rates over time.
Koornstra RH, Beelen KJ, Vincent AD, van der Noort V, van Diest PJ, Linn SC. Koornstra RH, et al. Among authors: van diest pj, van der noort v. Breast. 2015 Dec;24(6):705-12. doi: 10.1016/j.breast.2015.08.009. Epub 2015 Oct 1. Breast. 2015. PMID: 26429398 Clinical Trial.
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam M, van der Noort V, Kleijn M, Glas A, Mandjes I, Kleiterp S, Hilbers FS, Kruger DT, Bins AD, de Jong PC, Schiphorst PPJBM, van Dalen T, Flameling B, Rietbroek RC, Beeker A, van den Heiligenberg SM, Bakker SD, Wymenga ANM, Oving IM, Bijlsma RM, van Diest PJ, Vermorken JB, van Tinteren H, Linn SC. Opdam M, et al. Among authors: van den heiligenberg sm, van diest pj, van dalen t, van tinteren h, van der noort v. Breast Cancer Res Treat. 2022 Jul;194(2):265-278. doi: 10.1007/s10549-022-06618-z. Epub 2022 May 19. Breast Cancer Res Treat. 2022. PMID: 35587322 Free PMC article. Clinical Trial.
Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation.
Suelmann BBM, Bakhuis CFJ, van Dooijeweert C, Verloop J, Zweemer R, Linn S, van der Wall E, van Diest PJ. Suelmann BBM, et al. Among authors: van der wall e, van diest pj, van dooijeweert c. Breast Cancer Res Treat. 2022 Feb;192(1):175-189. doi: 10.1007/s10549-021-06471-6. Epub 2022 Jan 18. Breast Cancer Res Treat. 2022. PMID: 35039951
Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.
Baak JP, van Diest PJ, Janssen EA, Gudlaugsson E, Voorhorst FJ, van der Wall E, Vermorken JB; Collaborators of Multicenter Morphometric Mammary Carcinoma Project (MMMCP). Baak JP, et al. Among authors: van der wall e, van diest pj. Ann Oncol. 2008 Apr;19(4):649-54. doi: 10.1093/annonc/mdm535. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042836 Free article.
848 results